| Name | Title | Contact Details |
|---|
The Cardiovascular Research Foundation (CRF) in New York City is an independent, non-profit academic institution dedicated to improving the survival and quality of life of patients with cardiovascular disease through research and education.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Health-E-Quip is a Hutchinson, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Passport Health Northeast Pennsylvania is a Bethlehem, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
South Bend Clinic L L C is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. South Bend Clinic L L C is based in South Bend, IN. You can find more information on South Bend Clinic L L C at www.southbendclinic.com